Wanandy T - Search Results

1

Ultrarush versus semirush initiation of insect venom immunotherapy: a randomized controlled trial.

Brown SG, Wiese MD, van Eeden P, Stone SF, Chuter CL, Gunner J, Wanandy T, Phillips M, Heddle RJ. Brown SG, et al. Among authors: wanandy t. J Allergy Clin Immunol. 2012 Jul;130(1):162-8. doi: 10.1016/j.jaci.2012.02.022. Epub 2012 Mar 27. J Allergy Clin Immunol. 2012. PMID: 22460067 Clinical Trial.

2

Pilosulins: a review of the structure and mode of action of venom peptides from an Australian ant Myrmecia pilosula.

Wanandy T, Gueven N, Davies NW, Brown SG, Wiese MD. Wanandy T, et al. Toxicon. 2015 May;98:54-61. doi: 10.1016/j.toxicon.2015.02.013. Epub 2015 Feb 25. Toxicon. 2015. PMID: 25725257 Review.

3

Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.

Wanandy T, Dwyer HE, McLean L, Davies NW, Nichols D, Gueven N, Brown SGA, Wiese MD. Wanandy T, et al. Clin Exp Allergy. 2017 Nov;47(11):1478-1490. doi: 10.1111/cea.12987. Epub 2017 Aug 31. Clin Exp Allergy. 2017. PMID: 28756642

4

Towards complete identification of allergens in Jack Jumper (Myrmecia pilosula) ant venom and their clinical relevance: An immunoproteomic approach.

Wanandy T, Wilson R, Gell D, Rose HE, Gueven N, Davies NW, Brown SGA, Wiese MD. Wanandy T, et al. Clin Exp Allergy. 2018 Sep;48(9):1222-1234. doi: 10.1111/cea.13224. Epub 2018 Aug 3. Clin Exp Allergy. 2018. PMID: 29975807

5

Pharmaceutical and preclinical evaluation of Advax adjuvant as a dose-sparing strategy for ant venom immunotherapy.

Wanandy T, Honda-Okubo Y, Davies NW, Rose HE, Heddle RJ, Brown SGA, Woodman RJ, Petrovsky N, Wiese MD. Wanandy T, et al. J Pharm Biomed Anal. 2019 Aug 5;172:1-8. doi: 10.1016/j.jpba.2019.04.017. Epub 2019 Apr 9. J Pharm Biomed Anal. 2019. PMID: 31009889 Free PMC article.

6

Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.

Wanandy T, Mulcahy E, Lau WY, Brown SGA, Wiese MD. Wanandy T, et al. Clin Rev Allergy Immunol. 2022 Feb;62(1):123-144. doi: 10.1007/s12016-021-08858-1. Epub 2021 Jun 1. Clin Rev Allergy Immunol. 2022. PMID: 34075569 Review.

7

The development of Jack Jumper ant venom immunotherapy: our 25 years' experience.

Wanandy T, Le TA, Lau WY, Wiese MD, Heddle RJ, Brown SGA. Wanandy T, et al. Intern Med J. 2023 Sep;53(9):1716-1721. doi: 10.1111/imj.16217. Intern Med J. 2023. PMID: 37743244

8

Stability of dobutamine in continuous ambulatory delivery devices.

Al Madfai F, Valah B, Zaidi STR, Wanandy T, Ming LC, Peterson GM, Patel RP. Al Madfai F, et al. Among authors: wanandy t. J Clin Pharm Ther. 2018 Aug;43(4):530-535. doi: 10.1111/jcpt.12674. Epub 2018 Mar 2. J Clin Pharm Ther. 2018. PMID: 29500838

9

High Pyridine Generation in Ceftazidime-Icodextrin Admixtures Used to Treat Peritoneal Dialysis-associated Peritonitis.

Kaur H, Harmanjeet H, Wanandy T, Castelino RL, Sud K, Jose MD, Peterson GM, Patel RP. Kaur H, et al. Among authors: wanandy t. Clin Ther. 2019 Nov;41(11):2446-2451. doi: 10.1016/j.clinthera.2019.08.021. Epub 2019 Sep 28. Clin Ther. 2019. PMID: 31575441

10

Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices.

Patel RP, Jacob J, Sedeeq M, Ming LC, Wanandy T, Zaidi STR, Peterson GM. Patel RP, et al. Among authors: wanandy t. Clin Ther. 2018 Apr;40(4):664-667. doi: 10.1016/j.clinthera.2018.02.009. Epub 2018 Feb 26. Clin Ther. 2018. PMID: 29496321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters